Marc P. Frenay

Nice, 06000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

Journal: Bulletin du cancer

Published: March 23, 2018

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.

Journal: Cancer medicine

Published: October 13, 2015

GENESIS: a French national resource to study the missing heritability of breast cancer.

GENESIS: a French national resource to study the missing heritability of breast cancer.

Journal: BMC cancer

Published: February 02, 2015

Gliomas and BRCA genes mutations: fortuitous association or imputability?

Gliomas and BRCA genes mutations: fortuitous association or imputability?

Journal: Bulletin du cancer

Published: October 09, 2014

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 12, 2014

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

Journal: Journal of neurosurgery

Published: March 19, 2013

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 15, 2013

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Journal: Neuro-oncology

Published: February 09, 2013

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 17, 2012

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.

Journal: Nature genetics

Published: July 06, 2012

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Journal: Breast cancer research : BCR

Published: February 22, 2012

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: January 14, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026